Australia commences the next stage of COVID-19 vaccine rollout today

Summary

  • Australia begins the next phase of vaccine rollout by vaccinating people aged over 50 years.
  • The government has planned to vaccinate younger Australians with Pfizer’s vaccine amid the blood clot issue with AstraZeneca’s jab.
  • So far, the country has passed the milestone of administering two million doses of the COVID-19 vaccine.

Australia has commenced the next stage of its vaccination program today. In the phase 2a vaccination program, people aged over 50 years will get the jab. The shot will now be administered at General Practice Respiratory Clinics and state and territory mass vaccination clinics. However, regular GP clinics will be able to give vaccine shots in the upcoming weeks.

Eligible individuals are being offered the COVID-19 vaccine manufactured by Oxford and AstraZeneca Plc (LON:AZN) as the Federal government attempts to accelerate their vaccine rollout after several problems, such as supply issues, logistical issues and changing health advice, including the rare chance of blood clots. These issues have imposed delays to Australia's vaccine rollout and have dramatically altered the government’s plan for vaccinating Australians. The Australian government had planned to commence the vaccination drive in five phases.

Source: © Yakobchuk|Megapixl.com

In Victoria, the Australian government has opened 15 new state-run centres in addition to six mass vaccination centres already operating. Besides, other hubs will open in Cranbourne in the outer south-east of the city tomorrow, bringing the total number of vaccination centres to twenty-two. Moreover, Sydney is also set to develop a mass vaccination centre at Olympic Park, although it has not yet opened.

ALSO READ: COVID-19’s deadliest week kills over 93K globally, India remains worst-hit

Young Australian to get Pfizer vaccine shot

Amid the blood clotting risk associated with AstraZeneca’s vaccine, the government has planned to immunise younger Australians with Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) vaccines.

Source: Copyright © 2020 Kalkine Media Pty Ltd

Furthermore, state and territory-run vaccine facilities with sufficient refrigeration capacity that have been previously limited to AstraZeneca vaccines will be able to administer Pfizer jabs. This greater availability of Pfizer vaccine shot will only benefit people aged under 50 years in phases 1a and 1b.

Last week, Australia crossed the milestone of administering two million doses of the COVID-19 vaccine.

ALSO READ: All you need to know about Australia’s COVID-19 Vaccination Program


Disclaimer
The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK